All-Star Players

Wall Street

Top NASDAQ:ACRX Bull/Bear Pitches

Submitted March 10, 2015

It looks like my reservations about AcelRx when the share price was 7 a few weeks ago were right, although the stock went on to a new six-month high over 9 just before the Sword of Damocles dropped. People or institutions who were buying AcelRx in… More

B. Riley FBR rated the AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)’s stock as a Buy in a research note published on Tuesday, October 23rd, 2018 and posted a $9 price target on the common stock of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX). Other Wall Street experts have also recently posted reports on these shares. RBC Capital Mkts gave the stock an Outperform rating, while setting a price target at $5 in a research note from Friday, October 13th, 2017. Jefferies rated the stock as a Hold in a research note dated Friday, October 13th, 2017.

At the moment, there are a total of 8 analysts who cover AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) stock. Among that group, 2 of them gave BUY ratings, 4 of them rated the stock as OUTPERFORM, 2 recommended it as HOLD, 0 set the rating at UNDERPERFORM and 0 rated it as a SELL. Looking at the big picture from the data above, the average analyst rating for AcelRx Pharmaceuticals, Inc. is 2.00.

The company, which is valued at $181.80M, last published its earnings results on Friday, 11/02/2018 for the quarter that ended in Sep-18. The business posted revenue of $0.38 million for the three-month period, below -$0.53 million, compared to analysts’ forecasts of $0.91 million with a surprise factor of 58.46%. The organization posted -$0.21 earnings per share (EPS) for the three-month period, surpassing the Thomson Reuter’s analyst consensus estimate of -$0.21 amounting to a surprise factor of -1.20%.

At times, the stock market can get highly confusing – even for some of the most experienced traders. Even when the result is what you had expected, the market might suddenly decide to make an opposing movement. This can spark a great deal of doubt and second-guessing. Keeping tabs on historical price performance, as well as both long-term and short-term trends, can be very useful. Over the past 7 days, AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) stock has decreased in price by 14.55%. Looking backwards over the past quarter, these shares have fell -45.22%. Turning to look at the last 6 months, this stock has dropped 24.19% to its price. Since the beginning of the calendar year, this stock has moved up by 9.30%.

Now let’s examine some potential support and resistance levels for this particular stock. Following a recent spotcheck, the public organization AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) has been observed as trading -53.47% away from its 90-day high price. Taking a look at the other side of things, this stock has been trading +18.09% away from its 90-day low. Moving to a broader perspective, this stock has recently been trading -53.47% away from its 52-week high and +42.42% away from its 52-week low price.